CSIMarket
 
Veracyte Inc   (NASDAQ: VCYT)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Veracyte Inc's Suppliers Performance

VCYT's Supply Chain




 
VCYT Costs vs Sales of Suppliers Growth Veracyte Inc's cost of sales deteriorated by -91.43 % year on year, relative to one quarter ago cost of sales fell by -91.69 % in Q2.

More on VCYT Suppliers



Veracyte Inc's cost of sales deteriorated by -91.43 % year on year, compare to one quarter ago cost of sales fell by -91.69 % in Q2.

More on VCYT Suppliers




Veracyte Inc's Comment on Supply Chain


The company procures reagents, equipment, and other testing materials from sole suppliers, including components for collection kits sourced exclusively from these suppliers. Some items are unique to these sole-source providers. External vendors assemble and distribute the sample collection kits. Although alternate sourcing strategies have been developed, their effectiveness and availability remain uncertain. Supply interruptions could impact test processing, patient report delivery, and result in significant switching costs. To mitigate these risks, the company maintains higher inventory levels, which may lead to excess inventory and potential losses if test volumes decline or suppliers change. Supply challenges may also occur when introducing new tests or modifying existing ones.

Veracyte Inc's Comment on Supply Chain


The company procures reagents, equipment, and other testing materials from sole suppliers, including components for collection kits sourced exclusively from these suppliers. Some items are unique to these sole-source providers. External vendors assemble and distribute the sample collection kits. Although alternate sourcing strategies have been developed, their effectiveness and availability remain uncertain. Supply interruptions could impact test processing, patient report delivery, and result in significant switching costs. To mitigate these risks, the company maintains higher inventory levels, which may lead to excess inventory and potential losses if test volumes decline or suppliers change. Supply challenges may also occur when introducing new tests or modifying existing ones.







VCYT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Veracyte Inc 3,251.20 544.74 114.48 755
SUBTOTAL 0.00 0.00 0.00 -


Sources: Veracyte Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Veracyte Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.